1 |
BLOOMFIELD C D, ESTEY E, PLEYER L, et al. Time to repeal and replace response criteria for acute myeloid leukemia?[J]. Blood Rev, 2018,32(5): 416-425.
|
2 |
KOWAL J, TKACH M, THÉRY C. Biogenesis and secretion of exosomes[J]. Curr Opin Cell Biol, 2014,29: 116-125.
|
3 |
HENDERSON M C, AZORSA D O. The genomic and proteomic content of cancer cell-derived exosomes[J]. Front Oncol, 2012,2: 38.
|
4 |
BENITES B D, SILVA SANTOS DUARTE A D A, LONGHINI A L F, et al. Exosomes in the serum of acute myeloid leukemia patients induce dendritic cell tolerance: Implications for immunotherapy[J]. Vaccine, 2019,37(11): 1377-1383.
|
5 |
BOYIADZIS M, WHITESIDE T L. Exosomes in acute myeloid leukemia inhibit hematopoiesis[J]. Curr Opin Hematol, 2018,25(4): 279-284.
|
6 |
XU Y C, LIN Y S, ZHANG L, et al. microRNAs of bone marrow mesenchymal stem cell-derived exosomes regulate acute myeloid leukemia cell proliferation and apoptosis[J]. Chin Med J (Engl), 2020,133(23): 2829-2839.
|
7 |
BARRERA-RAMIREZ J, LAVOIE J R, MAGANTI H B, et al. Micro-RNA profiling of exosomes from marrow-derived mesenchymal stromal cells in patients with acute myeloid leukemia: implications in leukemogenesis[J]. Stem Cell Rev Rep, 2017,13(6): 817-825.
|
8 |
王卓然, 朱 冰, 余丽梅, 等. 干细胞衍生的外泌体在肝脏疾病治疗中的作用[J].临床肝胆病杂志,2023,39(3):699-706.
|
9 |
ZHANG L, KHADKA B, WU J Y, et al. Bone marrow mesenchymal stem cells-derived exosomal miR-425-5p inhibits acute myeloid leukemia cell proliferation, apoptosis, invasion and migration by targeting WTAP[J]. Onco Targets Ther, 2021,14: 4901-4914.
|
10 |
JIANG D F, WU X, SUN X Y, et al. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11[J].J Nanobiotechnol,2022,20(1):29.
|
11 |
CHENG H, DING J, TANG G S, et al. Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway[J]. Mol Med, 2021,27(1): 128.
|
12 |
ZHAO C, ZHAO Y, ZHAO J Q, et al. Acute myeloid leukemia cell-derived extracellular vesicles carrying microRNA-548ac regulate hematopoietic function via the TRIM28/STAT3 pathway[J]. Cancer Gene Ther, 2022, 29(7): 918-929.
|
13 |
JIANG L J, DENG T R, WANG D, et al. Elevated serum exosomal miR-125b level as a potential marker for poor prognosis in intermediate-risk acute myeloid leukemia[J]. Acta Haematol, 2018,140(3): 183-192.
|
14 |
LIN X, LING Q, LV Y F, et al. Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia[J]. Cancer Biomark, 2020,28(2): 151-158.
|
15 |
FANG Z G, WANG X Z, WU J Y, et al. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia[J]. Cancer Biomark, 2020,27(1): 1-9.
|
16 |
HORNICK N I, HUAN J Y, DORON B, et al. Serum exosome microRNA as a minimally-invasive early biomarker of AML[J]. Sci Rep, 2015,5: 11295.
|
17 |
HORIGUCHI H, KOBUNE M, KIKUCHI S, et al. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms[J]. Haematologica, 2016,101(4): 437-447.
|
18 |
ARBER D A, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016,127(20): 2391-2405.
|
19 |
MARQUÉS-GARCÍA F, ISIDORO-GARCÍA M. Protocols for exosome isolation and RNA profiling[J]. Methods Mol Biol, 2016,1434: 153-167.
|
20 |
DÖHNER H, WEISDORF D J, BLOOMFIELD C D. Acute myeloid leukemia[J]. N Engl J Med, 2015,373(12): 1136-1152.
|
21 |
HANDSCHUH L. Not only mutations matter: molecular picture of acute myeloid leukemia emerging from transcriptome studies[J]. J Oncol, 2019,2019: 7239206.
|
22 |
DÖHNER H, ESTEY E, GRIMWADE D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel[J]. Blood, 2017,129(4): 424-447.
|
23 |
SASAKI R, KANDA T, YOKOSUKA O, et al. Exosomes and hepatocellular carcinoma: from bench to bedside[J]. Int J Mol Sci, 2019,20(6):1406.
|
24 |
KOK V C, YU C C. Cancer-derived exosomes: their role in cancer biology and biomarker development[J]. Int J Nanomed, 2020,15: 8019-8036.
|
25 |
ZHAI L Y, LI M X, PAN W L, et al. In situ detection of plasma exosomal microRNA-1246 for breast cancer diagnostics by a Au nanoflare probe[J]. ACS Appl Mater Interfaces, 2018,10(46): 39478-39486.
|
26 |
STEVIC I, MÜLLER V, WEBER K, et al. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial[J]. BMC Med, 2018,16(1): 179.
|
27 |
HONG C S, DANET-DESNOYERS G, SHAN X C, et al. Human acute myeloid leukemia blast-derived exosomes in patient-derived xenograft mice mediate immune suppression[J]. Exp Hematol, 2019,76: 60-66.
|
28 |
CHEN T T, ZHANG G Z, KONG L Z, et al. Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy[J]. Life Sci, 2019,221: 187-195.
|
29 |
WANG B, WANG X T, HOU D Y, et al. Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling[J]. J Cell Physiol, 2019,234(7): 10602-10614.
|
30 |
ZHANG M, TIAN H, LI R R, et al. microRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation[J]. Pharmazie, 2018,73(6): 342-348.
|
31 |
LING C H, WANG X T, ZHU J J, et al. microRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer[J]. Cancer Med, 2019,8(7): 3520-3531.
|
32 |
HE Z, XUE H, LIU P, et al. miR-4286/TGF-β1/Smad3-negative feedback loop ameliorated vascular endothelial cell damage by attenuating apoptosis and inflammatory response[J]. J Cardiovasc Pharmacol, 2020,75(5): 446-454.
|
33 |
TSAI C C, CHEN T Y, TSAI K J, et al. NF-κB/miR-18a-3p and miR-4286/BZRAP1 axis may mediate carcinogenesis in Helicobacter pylori-associated gastric cancer[J]. Biomed Pharmacother, 2020,132: 110869.
|
34 |
HO K H, CHEN P H, SHIH C M, et al. miR-4286 is involved in connections between IGF-1 and TGF-β signaling for the mesenchymal transition and invasion by glioblastomas[J]. Cell Mol Neurobiol, 2022, 42(3): 791-806.
|